WO2025247379 - BENZIMIDAZOLE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/247379
Publication Date
04.12.2025
International Application No.
PCT/CN2025/098426
International Filing Date
30.05.2025
Title **
[English]
BENZIMIDAZOLE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
[French]
COMPOSÉ BENZIMIDAZOLE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
一种苯并咪唑类化合物、其制备方法及应用
Applicants **
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Inventors
ZHANG, Zheng
ZHOU, Peng
LIU, Yue
DENG, Zhou
ZHOU, You
ZHENG, Nuoyan
ZHANG, Yu
SHAN, Song
PAN, Desi
LU, Xianping
Priority Data
202410698214.4
30.05.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1826 | |
| EPO | Filing, Examination, Granting | 12682 | |
| Japan | Filing, Examination, Granting | 2016 | |
| South Korea | Filing, Examination, Granting | 1794 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
23,058
Contact Us
Abstract[English]
A benzimidazole compound represented by formula (I), a preparation method therefor, and use thereof. Specifically, the described compound can be used to treat diseases associated with the biological activity of MNK1 and/or MNK2.[French]
L'invention concerne un composé benzimidazole représenté par la formule (I), son procédé de préparation et son utilisation. Plus précisément, le composé décrit peut être utilisé pour traiter des maladies associées à l'activité biologique de MNK1 et/ou MNK2.[Chinese]
一种式(I)所示的苯并咪唑类化合物、其制备方法及其应用。具体地，前述化合物可用于治疗与MNK1和/或MNK2生物学活性相关的疾病。